Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Clinica Universidad de Navarra, Universidad de Navarra
Canadian Cancer Trials Group
MultiCare Health System Research Institute
Alliance for Clinical Trials in Oncology
Fudan University
Children's Oncology Group
Centre Paul Strauss
Baptist Health South Florida
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
National Taiwan University Hospital
Fudan University
Mayo Clinic
Tempus AI
Shanghai Tongji Hospital, Tongji University School of Medicine
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
NRG Oncology
The University of Hong Kong-Shenzhen Hospital
Mayo Clinic
Fudan University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
NRG Oncology
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Mayo Clinic
Herlev Hospital
Technische Universität Dresden
Herlev Hospital
Mayo Clinic
SWOG Cancer Research Network
University of Pittsburgh
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
Intergruppo Melanoma Italiano
IFOM ETS - The AIRC Institute of Molecular Oncology
IFOM ETS - The AIRC Institute of Molecular Oncology
Erasmus Medical Center
University of Manchester
Tongji Hospital
National Health Research Institutes, Taiwan
University of Michigan Rogel Cancer Center
Women's Hospital School Of Medicine Zhejiang University